PHE - Breast Cancer Test and Training System
A Contract Award Notice
by PUBLIC HEALTH ENGLAND
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- 1 year (est.)
- Value
- £506K
- Sector
- TECHNOLOGY
- Published
- 08 Apr 2022
- Delivery
- To 08 Apr 2023 (est.)
- Deadline
- n/a
Concepts
Location
London
2 buyers
- Public Health England London
1 supplier
- Nottingham University Nottingham
Description
Breast cancer screening system
Total Quantity or Scope
The contracts supports the Breast Cancer Screening Programme. The aim of the Programme is to maximise screening sensitivity (diagnosing the disease in the population who have the disease) whilst also maximising screening specificity (correctly identifying those who do not have the disease).
Award Detail
1 | Nottingham University (Nottingham)
|
Renewal Options
Extension 0f contract for one year beyond initial contract term.
Award Criteria
PRICE | _ |
CPV Codes
- 48780000 - System, storage and content management software package
Indicators
- Options are available.
- Award on basis of price.
Legal Justification
PHE originally went out to market using the open procedure with only one tenderer (the existing supplier) expressing an interest. Subsequently that tenderer notified PHE that they could no longer fulfil the requirements of the specification due to a key member of staff moving to the University of Nottingham. The tenderer subsequently transferred the intellectual property to the University of Nottingham to help facilitate the continuance of programme monitoring. The University of Nottingham have agreed to meet the specification requirements at the same cost as the bidder that originally tendered therefore ensuring value for money. As there is only one supplier capable of meeting the requirements PHE used the negotiated procedure without prior publication to award the contract to the University of Nottingham under Regulations 32 (2) (b) (ii) and (iii).
Reference
- FTS 009466-2022